Washington University AIDS Clinical Trial Unit
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Patel, Rupa
PILLAR, NCT05374525: A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United States

Completed
4
201
US
APRETUDE, Cabotegravir OLI
ViiV Healthcare
HIV Infections
08/24
08/24
PrEP@Home, NCT03569813: Pre-exposure Prophylaxis (PrEP) at Home

Completed
N/A
318
US
PrEP@Home System, Standard of Care
Emory University, National Institute of Mental Health (NIMH)
HIV/AIDS
04/23
04/23
PCORI PrEP, NCT04855773: Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

Recruiting
N/A
300
US
PrEPmate, Dot Diary
Public Health Foundation Enterprises, Inc., Patient-Centered Outcomes Research Institute, University of California, San Francisco, University of Miami, Whitman-Walker Health, San Francisco AIDS Foundation, WelTel, San Francisco Department of Public Health
HIV Infections, Sexually Transmitted Diseases
08/23
08/23
CREATE, NCT06062979: Clinical Effectiveness-Implementation Hybrid Type 2 Study on Home-Delivered Cabenuva for People Living With HIV Who Are Not Retained in Care

Enrolling by invitation
N/A
180
US
rilpivirine/cabotegravir
Whitman-Walker Institute, ViiV Healthcare
HIV
06/25
06/25

Download Options